newsfilter
← Latest News
PR Newswire·

Pulmatrix Announces Third Quarter 2023 Financial Results and Provides Corporate Update

Pulmatrix, Inc. (Nasdaq: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and...